NeuroPace to Present at the 4th Annual Wolfe Research Healthcare Conference

Rhea-AI Summary

NeuroPace, Inc. (NPCE), a medical device company, will participate in the 4th Annual Wolfe Research Healthcare Conference on November 16, 2022, at 2:40 p.m. Eastern Time. The event will feature a presentation from company management, and a live webcast will be accessible on the company's website. NeuroPace focuses on innovative treatments for epilepsy, particularly through its RNS System, which provides personalized, real-time therapy to reduce seizures in drug-resistant epilepsy patients. The webcast will be available for replay for at least 90 days post-event.

MOUNTAIN VIEW, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming 4^th Annual Wolfe Research Healthcare Conference. Management is scheduled to present on Wednesday, November 16th at 2:40 p.m. Eastern Time. A live webcast of this event, as well as an archived recording, will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com. The webcasts will be archived and available for replay for at least 90 days after the event.

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Philip Taylor
Gilmartin Group
investors@neuropace.com 

 

FAQ

When will NeuroPace present at the Wolfe Research Healthcare Conference?

NeuroPace will present at the Wolfe Research Healthcare Conference on November 16, 2022, at 2:40 p.m. Eastern Time.

How can I watch the NeuroPace presentation from the conference?

The NeuroPace presentation will be available via live webcast on the company's website, with an archive for replay for at least 90 days.

What is the main focus of NeuroPace, Inc.?

NeuroPace focuses on transforming the lives of people living with epilepsy by reducing or eliminating seizures through its RNS System.

What is the RNS System developed by NeuroPace?

The RNS System is the first commercially available, brain-responsive platform that delivers personalized treatment at the source of seizures.

What stock symbol does NeuroPace, Inc. trade under?

NeuroPace, Inc. trades under the stock symbol NPCE.